ASC-US: Clinical Trials

8 trials for ASC-US, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 2 unknown, 1 terminated. 3 Phase 2, 2 Not applicable, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Terminated 1
Not applicable2Completed 1, Withdrawn 1
Phase 11Recruiting 1
Phase 41Unknown 1

Follow ASC-US: new trials by email Literature Review of ASC-US trials Research Report on ASC-US

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities
EGCG and Quinine Sulfate Vaginal Suppository, Placebo - High-risk HPV (Any Strain), LSIL, Low Grade Squamous Intraepithelial Lesion
Phase 2RecruitingAmplexd Therapeutics, Inc.452026-04-302026-05-14
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Physical examination, Liquid-based cytology, Molecular screening - Atypical Squamous Cell of Undetermined Significance, ASC-US
Not applicableWithdrawnTimser SAPI de CV2026-02-272026-03-03
Study of Treatment for HPV16+ ASC-US or LSIL
pNGVL4aCRTE6E7L2, TA-CIN - ASC-US, LSIL
Phase 1RecruitingUniversity of Alabama at Birmingham302023-07-102026-05-15
"Lactobacillus Crispatus M247, LSIL and Microbiota"
Lactobacillus Crispatus M247 - Vaginal Flora Imbalance, ASC-US
Phase 4UnknownFondazione Policlinico Universitario Agostino Gemelli IRCCS902021-06-162023-04-11
Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
PVX-2, Placebo - ASC-US, ASC-H
Phase 2TerminatedPapiVax Biotech, Inc.162019-05-222024-06-17
HPV Test of Urine and Self Collected Vaginal Samples for Cervical Cancer Screening Study
Flocked Swab, Cervical Brush, HPV assay - ASC-US, LSIL
UnknownKorea University Guro Hospital3002018-05-042018-08-24
Probiotic Implementation as Help in Solving Vaginal Infections
Lactobacillus rhamnosus BMX 54 - Vaginal Infection, ASC-US
Phase 2CompletedUniversity of Roma La Sapienza1172015-02-012017-12-13
Can B12 and Folate Levels Predict HPV Penetration in Patients With ASCUS?
Vitamin B12 and folate - ASC-US, Human Papilloma Virus
Not applicableCompletedSanliurfa Mehmet Akif Inan Education and Research Hospital2002014-05-012019-04-05

Narrower conditions

Atypical Squamous Cells of the Cervix (8)  ·  Papillomavirus Infections (3)  ·  Uterine Cervical Dysplasia (3)  ·  Candidiasis, Vulvovaginal (1)  ·  Squamous Intraepithelial Lesions (1)  ·  Uterine Cervical Neoplasms (1)  ·  Vaginal Diseases (1)  ·  Vaginitis (1)

Broader conditions

Female Urogenital Diseases (8)  ·  Female Urogenital Diseases and Pregnancy Complications (8)  ·  Genital Diseases (8)  ·  Genital Diseases, Female (8)  ·  Morphological and Microscopic Findings (8)  ·  Neoplasms (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Precancerous Conditions (8)  ·  Urogenital Diseases (8)  ·  Uterine Cervical Diseases (8)  ·  Uterine Diseases (8)  ·  Uterine Cervical Dysplasia (5)  ·  Communicable Diseases (3)  ·  DNA Virus Infections (3)  ·  Disease Attributes (3)

Interventions

Biopsy (1)  ·  Colposcopy (1)  ·  Folic Acid (1)  ·  Human Papillomavirus DNA Tests (1)  ·  Restraint, Physical (1)  ·  Vitamin B 12 (1)  ·  epigallocatechin gallate (1)

Sponsors

Amplexd Therapeutics, Inc. (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Korea University Guro Hospital (1)  ·  PapiVax Biotech, Inc. (1)  ·  Sanliurfa Mehmet Akif Inan Education and Research Hospital (1)  ·  Timser SAPI de CV (1)  ·  University of Alabama at Birmingham (1)  ·  University of Roma La Sapienza (1)

Countries

United States (2)  ·  Hong Kong (1)  ·  Italy (1)  ·  Mexico (1)  ·  South Korea (1)

Top investigators

Jae Kwan Lee, MD, Ph.D. (1)  ·  Kar Kei Yung, MBBS (HK), MRCOG, FHKCOG, FHKA (1)  ·  Leopoldo E Gatica-Galina, MD in OB/GY & Gynecol Oncol (1)  ·  Mark Einstein, MD, MS (1)

Results publications

PMID 29304768, PMID 36607735